Ginseng total saponin or monomer saponin RbI vaccine immunological adjuvant application
A technology of total ginsenosides and immune adjuvants, which is applied to medical preparations containing active ingredients, antibody medical ingredients, and pharmaceutical formulas, and can solve problems such as irritation, toxicity, and restrictions on the use of oil adjuvants, and achieve short validity periods, The effect of extending the validity period
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0013] 1) Dissolving total ginsenosides or ginsenoside monomer Rb1 in physiological saline to prepare a solution of total ginsenosides and ginsenoside monomer Rb1. Mix inactivated Staphylococcus aureus and ginsenoside solution to prepare Staphylococcus aureus vaccines containing different adjuvants. Each milliliter of vaccine contains 10 6 Inactivated Staphylococcus aureus.
[0014] 2) Subcutaneously inject guinea pigs with 1 ml of the above vaccine. Two weeks later, the same method was used to inject once more. Before the first injection and 2 weeks after the second injection, blood samples were collected and serum was separated. Serum IgG content was detected by agar diffusion method. Elevated IgG levels indicate an enhanced humoral immune response.
[0015] Minute
Group
number
Each milliliter of vaccine adjuvant contains
quantity
Antibody (IgG) increase (last injection
2 weeks after ejaculation)
...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com